Reading Time: 6 minutesThe results of the MIROCALS clinical trial into the effects of low dose interleukin-2 (IL-2) on people with MND have now been published in The
Category: Treatments

Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this goal. Throughout 2024, we saw many

UK clinical trial updates to look out for in 2025
Reading Time: 6 minutesNew and effective treatments for MND are urgently needed and many scientists around the world are working towards this. Throughout 2024, we saw many new

Shining a light on the next generation of MND researchers
Reading Time: 5 minutesThe 35th International Symposium on ALS/MND, organised by the MND Association, was held on 6-8 December 2024 and welcomed over 1200 delegates to Montreal, Canada

Finding treatments and improving care in MND
Reading Time: 7 minutesIt’s that time of year again when we’re counting down to the annual International Symposium on ALS/MND! This year marks the 35th Symposium, the largest scientific

Reading Time: 5 minutesIn July we hosted our annual event for early career researchers (ECRs) in the UK. MND EnCouRage UK is a two day event which aims

Reading Time: 5 minutesWhile we work hard for a cure, it is essential we support those living with MND now. Professor Chris McDermott, Professor of Translational Neurology at

Reading Time: 5 minutesBuilding relationships with key research institutes across the UK is vital in pushing research forward in the fight against MND. As of 31 December 2023,

Reading Time: 5 minutesDespite extensive research, the causes of MND remain largely unknown. Recent investigations have begun to shed light on the gut microbiome and whether it may

Reading Time: 10 minutesFor the purposes of this blog, ALS should be taken to mean ALS/MND. In September 2020 we published a blog article discussing Dr Rick Bedlack’s